000 01224 a2200325 4500
005 20250514003633.0
264 0 _c20011220
008 200112s 0 0 eng d
022 _a1120-009X
024 7 _a10.1179/joc.2001.13.3.244
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJones, R N
245 0 0 _aIn vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent.
_h[electronic resource]
260 _bJournal of chemotherapy (Florence, Italy)
_cJun 2001
300 _a244-54 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aBacterial Infections
_xdrug therapy
650 0 4 _aDrug Evaluation
650 0 4 _aGlycopeptides
650 0 4 _aGram-Negative Bacteria
_xdrug effects
650 0 4 _aGram-Positive Bacteria
_xdrug effects
650 0 4 _aIn Vitro Techniques
650 0 4 _aTeicoplanin
_xanalogs & derivatives
700 1 _aBiedenbach, D J
700 1 _aJohnson, D M
700 1 _aPfaller, M A
773 0 _tJournal of chemotherapy (Florence, Italy)
_gvol. 13
_gno. 3
_gp. 244-54
856 4 0 _uhttps://doi.org/10.1179/joc.2001.13.3.244
_zAvailable from publisher's website
999 _c11379356
_d11379356